Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have body mass index (BMI) ≥30 kilograms per square meter (kg/m2) or BMI ≥25.0 kg/m2 and at least 1 of the following weight-related comorbidities at screening:
* hypertension
* dyslipidemia
* obstructive sleep apnea, or
* cardiovascular disease
Have a history of at least one unsuccessful dietary effort to lose body weight
You may not be if
Have type 1 diabetes, type 2 diabetes, or any other types of diabetes
Have an unstable body weight within 90 days prior to screening
Have New York Heart Association functional classification IV congestive heart failure or an acute cardiovascular condition within 90 days prior to screening
Have acute or chronic hepatitis or pancreatitis
Are taking other medications or alternative remedies to manage weight loss
Clareo Health | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
